Boston Scientific (BSX) PT Raised to $116 at RBC; 'Solid PFA & Broad Portfolio Momentum Offer Room for 2025 Upside'
Tweet Send to a Friend
RBC Capital analyst Shagun Singh raised the price target on Boston Scientific (NYSE: BSX) to $116.00 (from $105.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
